Allogeneic haematopoietic stem cell transplantation for advanced stage mycosis fungoides and Sézary syndrome: never-late, never-never?
- 1 February 2021
- journal article
- editorial
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 56 (6), 1232-1234
- https://doi.org/10.1038/s41409-020-01150-4
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Efficacy of Allogeneic Hematopoietic Cell Transplantation in Cutaneous T Cell Lymphoma: Results of a Systematic Review and Meta-AnalysisTransplantation and Cellular Therapy, 2019
- The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomasBlood, 2019
- Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trialThe Lancet Oncology, 2018
- Allogeneic hematopoietic stem cell transplantation in Primary Cutaneous T Cell LymphomaAnnals of Hematology, 2018
- Systemic Treatment Options for Advanced-Stage Mycosis Fungoides and Sézary SyndromeCurrent Oncology Reports, 2018
- Brentuximab vedotin or physician's choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trialThe Lancet, 2017
- Long-Term Outcome of Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A European Society for Blood and Marrow Transplantation Lymphoma Working Party Extended AnalysisJournal of Clinical Oncology, 2014
- Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndromeBone Marrow Transplantation, 2014
- Incidence and survival patterns of cutaneous T-cell lymphomas in the United StatesLeukemia & Lymphoma, 2012
- Allogeneic Hematopoietic Cell Transplantation for Patients With Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of the Lymphoma Working Party of the European Group for Blood and Marrow TransplantationJournal of Clinical Oncology, 2010